Automated Insulin Delivery for Type 1 Diabetes: Present and Future.

Q3 Medicine

Diabetes Spectrum Pub Date : 2025-08-15 eCollection Date: 2025-01-01 DOI:10.2337/dsi25-0003

Tugce Akcan, Ming Yeh Lee, Leor Needleman, Rayhan A Lal

引用次数: 0

Abstract

Advancements in automated insulin delivery (AID) systems have transformed type 1 diabetes management, making AID the most effective technology for improving metabolic outcomes and quality of life in individuals with the disease. In this article, we review the available AID systems and their key features through case vignettes that illustrate their real-world applications in type 1 diabetes management. We then examine existing gaps in technology and explore future advancements to further enhance AID functionality and adoption.

查看原文本刊更多论文

1型糖尿病的自动胰岛素输送：现在和未来。

自动化胰岛素输送（AID）系统的进步已经改变了1型糖尿病的管理，使AID成为改善糖尿病患者代谢结果和生活质量的最有效技术。在这篇文章中，我们回顾了现有的AID系统及其主要特点，并通过实例说明了它们在1型糖尿病管理中的实际应用。然后，我们检查现有的技术差距，并探索未来的进展，以进一步加强艾滋病的功能和采用。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Diabetes Spectrum Medicine-Internal Medicine

CiteScore

2.70

自引率

0.00%

发文量

期刊介绍： The mission of Diabetes Spectrum: From Research to Practice is to assist health care professionals in the development of strategies to individualize treatment and diabetes self-management education for improved quality of life and diabetes control. These goals are achieved by presenting review as well as original, peer-reviewed articles on topics in clinical diabetes management, professional and patient education, nutrition, behavioral science and counseling, educational program development, and advocacy. In each issue, the FROM RESEARCH TO PRACTICE section explores, in depth, a diabetes care topic and provides practical application of current research findings.